Literature DB >> 26070761

Methcathinone "Kitchen Chemistry" and Permanent Neurological Damage.

Katrin Sikk1, Pille Taba2.   

Abstract

Methcathinone abuse is a significant cause of parkinsonism among young patients in the Eastern European countries. The drug is synthesized from over-the-counter cold remedies containing ephedrine or pseudoephedrine. The final mixture contains a high concentration of manganese if potassium permanganate is used as the oxidant agent. Though manganese is an essential trace element and its homeostasis is well maintained, exposure to a high level of manganese is neurotoxic. The use of manganese-contaminated methcathinone may cause permanent neurological damage and severe disability. Drug users develop a distinctive extrapyramidal syndrome that resembles classic manganese intoxication. Methcathinone could have additive neurotoxic effect to the progression of parkinsonism. The most prevalent symptoms are symmetrical bradykinesia, dystonias, and early postural, gait, and speech impairment. After cessation of exposure, the syndrome is generally irreversible and can even progress.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ephedrone; Manganese; Methcathinone; Parkinsonism

Mesh:

Substances:

Year:  2015        PMID: 26070761     DOI: 10.1016/bs.irn.2015.02.002

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  9 in total

1.  Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case-Control Study in South Korea.

Authors:  Hae-Young Park; Ji-Won Park; Hyun Soon Sohn; Jin-Won Kwon
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

2.  Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.

Authors:  Monica R Langley; Shivani Ghaisas; Muhammet Ay; Jie Luo; Bharathi N Palanisamy; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2017-06-20       Impact factor: 4.294

3.  Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports.

Authors:  Michal Ordak; Aleksandra Zmysłowska; Miłosz Bielski; Daniel Rybak; Maja Tomaszewska; Katarzyna Wyszomierska; Aleksandra Kmiec; Natalia Garlicka; Maria Zalewska; Michal Zalewski; Tadeusz Nasierowski; Elzbieta Muszynska; Magdalena Bujalska-Zadrozny
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

4.  Impaired delay discounting and time sensitivity in methcathinone use disorder.

Authors:  Ningning Zeng; Tianshu Shi; Hui Zheng; Hang-Bin Zhang; Li-Xun Wang; Zhu-Yuan Liang; Bomin Sun; Yanhui Liao; Li-Lin Rao; Bo Yang; Ti-Fei Yuan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-01-29       Impact factor: 5.270

5.  Problem-solving deficits in methcathinone use disorder.

Authors:  Hang-Bin Zhang; Di Zhao; Yu-Ping Liu; Li-Xun Wang; Bo Yang; Ti-Fei Yuan
Journal:  Psychopharmacology (Berl)       Date:  2021-07-22       Impact factor: 4.530

Review 6.  Manganese-induced neurodegenerative diseases and possible therapeutic approaches.

Authors:  Airton C Martins; Priscila Gubert; Gustavo R Villas Boas; Marina Meirelles Paes; Abel Santamaría; Eunsook Lee; Alexey A Tinkov; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2020-09-02       Impact factor: 4.618

7.  Neuropharmacology of Synthetic Cathinones.

Authors:  Michael H Baumann; Hailey M Walters; Marco Niello; Harald H Sitte
Journal:  Handb Exp Pharmacol       Date:  2018

8.  Simultaneous Quantitative Determination of Synthetic Cathinone Enantiomers in Urine and Plasma Using GC-NCI-MS.

Authors:  Rashed Alremeithi; Mohammed A Meetani; Anas A Alaidaros; Adnan Lanjawi; Khalid Alsumaiti
Journal:  J Anal Methods Chem       Date:  2018-04-01       Impact factor: 2.193

9.  Subacute administration of both methcathinone and manganese causes basal ganglia damage in mice resembling that in methcathinone abusers.

Authors:  Andres Asser; Atsuko Hikima; Mari Raki; Kim Bergström; Sarah Rose; Julius Juurmaa; Villem Krispin; Mari Muldmaa; Stella Lilles; Hanna Rätsep; Peter Jenner; Sulev Kõks; Pekka T Männistö; Pille Taba
Journal:  J Neural Transm (Vienna)       Date:  2019-11-30       Impact factor: 3.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.